{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:44:40Z","timestamp":1786985080962,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008303","name":"Department for Employment and Learning, Northern Ireland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008303","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.bcp.2022.115398","type":"journal-article","created":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T02:03:01Z","timestamp":1672020181000},"page":"115398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Antidiabetic actions of GPR55 agonist Abn-CBD and sitagliptin in obese-diabetic high fat fed mice"],"prefix":"10.1016","volume":"208","author":[{"given":"Andrew G.","family":"McCloskey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Miskelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan A.","family":"Lafferty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Flatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aine M","family":"McKillop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bcp.2022.115398_b0005","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3390\/ijms22020622","article-title":"GPR55 Receptor Activation by the N-Acyl Dopamine Family Lipids Induces Apoptosis in Cancer Cells via the Nitric Oxide Synthase (nNOS) Over-Stimulation","volume":"22","author":"Akimov","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2022.115398_b0010","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.908198","article-title":"Medical cannabis activity against inflammation: active compounds and modes of action","volume":"13","author":"Anil","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2022.115398_b0015","doi-asserted-by":"crossref","DOI":"10.3390\/metabo6010006","article-title":"Lysophosphatidylinositol Signalling and Metabolic Diseases","volume":"6","author":"Arifin","year":"2016","journal-title":"Metabolites"},{"issue":"6","key":"10.1016\/j.bcp.2022.115398_b0020","first-page":"551","article-title":"C-reactive protein: adjunct to cardiovascular risk assessment","volume":"58","author":"Bahadursingh","year":"2009","journal-title":"West Indian Med. J."},{"issue":"1","key":"10.1016\/j.bcp.2022.115398_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tips.2005.11.003","article-title":"In silico patent searching reveals a new cannabinoid receptor","volume":"27","author":"Baker","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.bcp.2022.115398_b0030","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/ijo.2012.116","article-title":"(2013) CB(1) blockade-induced weight loss over 48 weeks decreases liver fat in proportion to weight loss in humans","volume":"37","author":"Bergholm","year":"2005","journal-title":"Int. J. Obes. (Lond)"},{"key":"10.1016\/j.bcp.2022.115398_b0035","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/S0026-0495(98)90304-3","article-title":"Differential effects of fat and sucrose on body composition in A\/J and C57BL\/6 mice","volume":"47","author":"Black","year":"1998","journal-title":"Metabolism"},{"key":"10.1016\/j.bcp.2022.115398_b0040","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/oby.2007.608","article-title":"High-fat diets: modeling the metabolic disorders of human obesity in rodents","volume":"15","author":"Buettner","year":"2007","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.bcp.2022.115398_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120596","article-title":"The oncogenic lysophosphatidylinositol (LPI)\/GPR55 signaling","volume":"301","author":"Calvillo-Robledo","year":"2022","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.bcp.2022.115398_b0050","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/s41598-017-01062-2","article-title":"Inflammatory and neuropathic nociception is preserved in GPR55 Knockout Mice","volume":"7","author":"Carey","year":"2017","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.bcp.2022.115398_b0055","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.molmet.2017.06.019","article-title":"Human beta cell mass and function in diabetes: Recent advances in knowledge and technologies to understand disease pathogenesis","volume":"6","author":"Chen","year":"2017","journal-title":"Molecular metabolism"},{"issue":"9","key":"10.1016\/j.bcp.2022.115398_b0060","first-page":"409","article-title":"C-reactive protein: a new risk assessment tool for cardiovascular disease","volume":"105","author":"Clearfield","year":"2005","journal-title":"J. Am. Osteopath. Assoc."},{"issue":"12","key":"10.1016\/j.bcp.2022.115398_b0065","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.tips.2020.10.001","article-title":"Unintended Effects of GPCR-Targeted Drugs on the Cancer Phenotype","volume":"41","author":"Cornwell","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2022.115398_b0070","doi-asserted-by":"crossref","first-page":"229","DOI":"10.4103\/0253-7613.68425","article-title":"Nature of action of Sitagliptin, the dipeptidyl peptidase-IV inhibitor in diabetic animals","volume":"42","author":"Davis","year":"2010","journal-title":"Indian J. Pharmacol."},{"key":"10.1016\/j.bcp.2022.115398_b0075","doi-asserted-by":"crossref","unstructured":"J, Divers, N.D, Palmer, C.D, Langefeld, W.M, Brown, L, Lu, P.J, Hicks, S.C, Smith, J, Xu, J.G, Terry, T.C, Register, L.E, Wagenknecht, J.S, Parks, L, Ma, G.C, Chan, S.G, Buxbaum, A, Correa, S, Musani, J.G, Wilson, H.A, Taylor, D.W, Bowden, J.J, Carr, B.I, Freedman, Genome-wide association study of coronary artery calcified atherosclerotic plaque in African Americans with type 2 diabetes.BMC Genetics,18 1 2017 105-017-0572-9.","DOI":"10.1186\/s12863-017-0572-9"},{"key":"10.1016\/j.bcp.2022.115398_b0080","first-page":"52","volume":"43","author":"Donvito","year":"2018","journal-title":"The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain"},{"key":"10.1016\/j.bcp.2022.115398_b0090","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/BF00252768","article-title":"Abnormal plasma glucose and insulin responses in heterozygouslean (ob\/+) mice","volume":"20","author":"Flatt","year":"1981","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.bcp.2022.115398_b0095","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1210\/en.2009-1277","article-title":"{beta}-Cell mass dynamics and islet cell plasticity in human type 2 diabetes","volume":"151","author":"Hanley","year":"2010","journal-title":"Endocrinology"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2022.115398_b0100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cell.2017.11.033","article-title":"Pharmacogenomics of GPCR Drug Targets","volume":"172","author":"Hauser","year":"2018","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.bcp.2022.115398_b0105","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.clpt.2005.09.002","article-title":"Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: results from two randomized, double-blind, placebo-controlled studies with single oral doses","volume":"78","author":"Herman","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.bcp.2022.115398_b0110","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.3390\/ijms23084170","article-title":"Anti-Inflammatory and Antiviral Effects of Cannabinoids in Inhibiting and Preventing SARS-CoV-2 Infection","volume":"23","author":"Janecki","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bcp.2022.115398_b0115","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/sj.bjp.0707419","article-title":"The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects","volume":"152","author":"Johns","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.bcp.2022.115398_b0120","first-page":"1663","article-title":"Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects","volume":"42","author":"Kahn","year":"1993","journal-title":"Evidence for a hyperbolic function. Diabetes"},{"issue":"2","key":"10.1016\/j.bcp.2022.115398_b0125","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1185\/030079908X261069","article-title":"Sitagliptin, a DPP-4 inhibitor for the treatment of patients with type 2 diabetes: a review of recent clinical trials","volume":"24","author":"Karasik","year":"2008","journal-title":"Curr. Med. Res. Opin."},{"issue":"8","key":"10.1016\/j.bcp.2022.115398_b0135","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/1354750X.2016.1265002","article-title":"Potential of lysophosphatidylinositol as a prognostic indicator of cardiac arrest using a rat model","volume":"22","author":"Kim","year":"2017","journal-title":"Biomarkers: Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals"},{"issue":"6","key":"10.1016\/j.bcp.2022.115398_b0140","doi-asserted-by":"crossref","first-page":"e21673","DOI":"10.1096\/fj.202100245R","article-title":"Lysophosphatidylinositol, especially albumin-bound form, induces inflammatory cytokines in macrophages","volume":"35","author":"Kurano","year":"2021","journal-title":"FASEB J."},{"issue":"12","key":"10.1016\/j.bcp.2022.115398_b0145","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/dom.12780","article-title":"GPR55-dependent stimulation of insulin secretion from isolated mouse and human islets of Langerhans","volume":"18","author":"Liu","year":"2016","journal-title":"Diabetes Obes. Metab."},{"issue":"1","key":"10.1016\/j.bcp.2022.115398_b0150","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12933-022-01516-6","article-title":"Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management","volume":"21","author":"Ma","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"issue":"3","key":"10.1016\/j.bcp.2022.115398_b0155","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/157015906778019527","article-title":"Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes","volume":"4","author":"Manzanares","year":"2006","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.bcp.2022.115398_b0160","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ejphar.2017.12.039","article-title":"Abnormal cannabidiol confers cardioprotection in diabetic rats independent of glycemic control","volume":"820","author":"Matouk","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2022.115398_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105104","article-title":"Pharmacological potential of novel agonists for FFAR4 on islet and enteroendocrine cell function and glucose homeostasis","volume":"142","author":"McCloskey","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bcp.2022.115398_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2019.170251","article-title":"CRISPR\/Cas9 gene editing demonstrates metabolic importance of GPR55 in the modulation of GIP release and pancreatic beta cell function","volume":"125","author":"McCloskey","year":"2020","journal-title":"Peptides"},{"issue":"5","key":"10.1016\/j.bcp.2022.115398_b0175","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/bph.12356","article-title":"Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice","volume":"170","author":"McKillop","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.bcp.2022.115398_b0180","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1007\/s00125-016-4108-z","article-title":"Metabolic effects of orally administered small-molecule agonists of GPR55 and GPR119 in multiple low-dose streptozotocin-induced diabetic and incretin-receptor-knockout mice","volume":"59","author":"McKillop","year":"2016","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.bcp.2022.115398_b0185","doi-asserted-by":"crossref","first-page":"994","DOI":"10.2337\/db13-1013","article-title":"Insulin resistance alters islet morphology in nondiabetic humans","volume":"63","author":"Mezza","year":"2014","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.bcp.2022.115398_b0190","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/can.2017.0036","article-title":"An Update on Non-CB1, Non-CB2 Cannabinoid Related G-Protein-Coupled Receptors","volume":"2","author":"Morales","year":"2017","journal-title":"Cannabis Cannabinoid Res."},{"issue":"2","key":"10.1016\/j.bcp.2022.115398_b0195","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2337\/db11-0649","article-title":"The L-alpha-lysophosphatidylinositol\/GPR55 system and its potential role in human obesity","volume":"61","author":"Moreno-Navarrete","year":"2012","journal-title":"Diabetes"},{"issue":"14","key":"10.1016\/j.bcp.2022.115398_b0200","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.2174\/092986710790980005","article-title":"Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown","volume":"17","author":"Reggio","year":"2010","journal-title":"Curr. Med. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2022.115398_b0205","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/dom.13180","article-title":"LH-21 and abnormal cannabidiol improve beta-cell function in isolated human and mouse islets through GPR55-dependent and -independent signalling","volume":"20","author":"Ruz-Maldonado","year":"2018","journal-title":"Diabetes Obes. Metab."},{"issue":"7","key":"10.1016\/j.bcp.2022.115398_b0210","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","article-title":"The orphan receptor GPR55 is a novel cannabinoid receptor","volume":"152","author":"Ryberg","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2022.115398_b0215","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/432607","article-title":"Rimonabant: From RIO to Ban","volume":"2011","author":"Sam","year":"2011","journal-title":"J. Obes."},{"issue":"2","key":"10.1016\/j.bcp.2022.115398_b0220","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0169-328X(98)00277-0","article-title":"Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain","volume":"64","author":"Sawzdargo","year":"1999","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"10","key":"10.1016\/j.bcp.2022.115398_b0235","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/nmo.12639","article-title":"The GPR55 antagonist CID16020046 protects against intestinal inflammation","volume":"27","author":"Stancic","year":"2015","journal-title":"Neurogastroenterol. Motility : The Official J. Eur. Gastrointestinal Motility Soc."},{"issue":"2\u20133","key":"10.1016\/j.bcp.2022.115398_b0240","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ejphar.2006.12.016","article-title":"2-Arachidonylglyceryl ether and abnormal cannabidiol-induced vascular smooth muscle relaxation in rabbit pulmonary arteries via receptor-pertussis toxin sensitive G proteins-ERK1\/2 signaling","volume":"559","author":"Su","year":"2007","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2022.115398_b0245","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.pbb.2008.05.010","article-title":"Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures\u2013a short review","volume":"90","author":"Svizenska","year":"2008","journal-title":"Pharmacol. Biochem. Behav"},{"issue":"3","key":"10.1016\/j.bcp.2022.115398_b0250","doi-asserted-by":"crossref","first-page":"R191","DOI":"10.1530\/JME-16-0253","article-title":"GPR55: a new promising target for metabolism?","volume":"58","author":"Tudur\u00ed","year":"2017","journal-title":"J. Mol. Endocrinol."},{"issue":"11","key":"10.1016\/j.bcp.2022.115398_b0255","doi-asserted-by":"crossref","first-page":"e0140592","DOI":"10.1371\/journal.pone.0140592","article-title":"Anti-Obesity Effect of the CB2 Receptor Agonist JWH-015 in Diet-Induced Obese Mice","volume":"10","author":"Verty","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2022.115398_b0260","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/978-1-61779-430-8_27","article-title":"A mouse model of diet-induced obesity and insulin resistance.","volume":"821","author":"Wang","year":"2012","journal-title":"Methods in molecular biology (Clifton N.J.)"},{"key":"10.1016\/j.bcp.2022.115398_b0265","doi-asserted-by":"crossref","DOI":"10.1007\/s12031-022-02020-y","article-title":"Pharmacological Activation of GPR55 improved cognitive impairment induced by lipopolysaccharide in mice","author":"Wang","year":"2022","journal-title":"J. molecular neurosci. MN"},{"key":"10.1016\/j.bcp.2022.115398_b0270","first-page":"658","article-title":"Dietary obesity in the mouse: interaction of strain with diet composition","volume":"268","author":"West","year":"1995","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bcp.2022.115398_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2022.173340","article-title":"Activation of GPR55 attenuates cognitive impairment, oxidative stress, neuroinflammation, and synaptic dysfunction in a streptozotocin-induced Alzheimer's mouse model","volume":"214","author":"Xiang","year":"2022","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.bcp.2022.115398_b0280","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1515\/jbcpp-2015-0080","article-title":"GPR55 - a putative \u201ctype 3\u201d cannabinoid receptor in inflammation","volume":"27","author":"Yang","year":"2016","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2022.115398_b0285","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1210\/jc.2012-3832","article-title":"Predominance of \u03b2-cell neogenesis rather than replication in humans with an impaired glucose tolerance and newly diagnosed diabetes","volume":"98","author":"Yoneda","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295222004944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295222004944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:17:15Z","timestamp":1762096635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295222004944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":53,"alternative-id":["S0006295222004944"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2022.115398","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antidiabetic actions of GPR55 agonist Abn-CBD and sitagliptin in obese-diabetic high fat fed mice","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2022.115398","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115398"}}